Why Medical Device Penetration Testing Matters in Healthcare Cybersecurity

By Dwight Grupp | GalaLayo Cybersecurity

Connected medical devices such as infusion pumps, imaging systems, and implantable devices are prime targets for cyberattacks. These systems often operate in complex environments with legacy technology, making them vulnerable to exploitation.

Key risks include:

• Patient safety compromise through device manipulation or dosage changes

• Exposure of Protected Health Information (PHI), leading to HIPAA compliance violations

• Ransomware attacks disrupting hospital operations and care delivery

• Financial losses and regulatory penalties

  
  

Healthcare remains one of the most targeted industries, making IoMT security and penetration testing services a top priority.

Scope of Medical Device Security Testing (MDPT)

A comprehensive medical device penetration testing strategy must evaluate the full attack surface across multiple layers:

Device Layer (Embedded & Firmware Security)

Identify firmware vulnerabilities, hardcoded credentials, insecure boot processes, and embedded operating system weaknesses. Assess physical access risks such as USB ports and JTAG interfaces.

Application Layer (Web & Mobile Security)

Test web applications and mobile interfaces for common vulnerabilities, including authentication flaws, authorization gaps, and OWASP Top 10 risks. API security testing ensures secure data exchange.

Network Layer (Healthcare Network Security)

Analyze communication protocols such as HL7, DICOM, and MQTT. Validate encryption standards (TLS, certificates) and identify lateral movement risks across hospital networks.

Cloud & Backend Systems (IoMT Cloud Security)

Evaluate device-to-cloud integrations, data storage security, identity and access management (IAM), and access control mechanisms.

Supply Chain & Third-Party Risk

Assess Software Bill of Materials (SBOM), third-party components, and secure over-the-air (OTA) update mechanisms to reduce supply chain vulnerabilities.

Regulatory Compliance for Medical Device Cybersecurity

Medical device penetration testing must align with major healthcare and cybersecurity frameworks to ensure compliance and risk management:

• FDA Cybersecurity Guidance for secure-by-design medical devices and testing validation

• HIPAA compliance requirements for PHI protection and data security

• ISO 14971 for medical device risk management and patient safety

• IEC 62304 for secure software development lifecycle (SDLC)

• NIST Cybersecurity Framework (CSF 2.0) for risk-based cybersecurity strategy

• NIST SP 800-53 and 800-171 for security control baselines

Aligning MDPT with these frameworks strengthens both security posture and regulatory readiness.

Medical Device Penetration Testing Methodology

An effective MDPT approach follows a structured and safety-first penetration testing methodology:

Pre-Engagement & Scoping

Define device types, environments, and testing scope. Establish strict safety controls to avoid disruption to clinical operations.

Threat Modeling & Risk Analysis

Map IoMT attack surfaces, including devices, networks, and cloud systems. Identify threat scenarios such as ransomware, insider threats, and advanced persistent threats (APTs).

Security Testing Phases

Perform static analysis of firmware and code, dynamic testing of live systems, network penetration testing, and API security testing.

Controlled Exploitation

Validate vulnerabilities using proof-of-concept testing while ensuring no impact on patient safety or device functionality.

Reporting & Risk Prioritization

Deliver detailed findings using CVSS scoring combined with patient safety impact. Map results to FDA, HIPAA, and NIST cybersecurity requirements.

Challenges in Medical Device Penetration Testing

Medical device security testing presents unique challenges in healthcare environments:

• Balancing patient safety with depth of penetration testing

• Legacy medical devices with limited patching capabilities

• Regulatory constraints slowing remediation processes

• Operational uptime requirements limiting testing windows

• Resource constraints affecting full-stack testing coverage

Despite these challenges, proactive IoMT security testing significantly reduces cyber risk.

30-60-90 Day Roadmap for IoMT Security and MDPT

30 Days: Establish Visibility

Create a complete inventory of IoMT assets. Classify devices based on criticality and patient safety impact. Conduct non-intrusive vulnerability scanning and review existing healthcare cybersecurity policies.

60 Days: Implement Security Controls

Perform targeted medical device penetration testing on high-risk systems. Apply Zero Trust network segmentation and enforce multi-factor authentication (MFA). Develop a centralized risk register.

90 Days: Mature Cybersecurity Program

Integrate MDPT into secure SDLC processes and procurement requirements. Establish continuous penetration testing and red teaming. Align reporting with NIST CSF and FDA cybersecurity expectations.

Conclusion: Securing the Future of Connected Healthcare

Medical Device Penetration Testing is a cornerstone of modern healthcare cybersecurity. As IoMT adoption grows and cyber threats evolve, organizations must invest in proactive security testing to protect patient safety, ensure HIPAA compliance, and defend against ransomware in healthcare environments.

Organizations that prioritize medical device security testing today will be better positioned to manage risk, maintain compliance, and safeguard critical healthcare systems in the future.